Staff Directory Contact Us

The Nathan S. Kline Institute for Psychiatric Research

Biomarkers of Response to Ketamine in Depression

This research study aims to identify markers that predict what patients with depression will improve when treated with ketamine.

Study Length: 
5 visits over about one month
Disorder/Condition: 
Treatment-Resistant Depression
Inclusion Criteria: 

Men or women between the ages of 18 and 65 who have not had a satisfactory response to antidepressant medication. Participants should be in good general health and willing to use birth control if of child bearing potential.

Study Title (brief): 
Biomarkers of Response to Ketamine in Depression
Study Description (brief): 

This research study aims to identify markers that predict what patients with depression will improve when treated with ketamine.

Study Contact: 

Danielle Rette, 845-398-7752, depression@nki.rfmh.org